» Articles » PMID: 28755064

Inclusion of Diverse Populations in Genomic Research and Health Services: Genomix Workshop Report

Overview
Publisher Springer
Specialty Health Services
Date 2017 Jul 30
PMID 28755064
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Clinical genetic services and genomic research are rapidly developing but, historically, those with the greatest need are the least to benefit from these advances. This encompasses low-income communities, including those from ethnic minority and indigenous backgrounds. The "Genomix" workshop at the European Society of Human Genetics (ESHG) 2016 conference offered the opportunity to consider possible solutions for these disparities from the experiences of researchers and genetic healthcare practitioners working with underserved communities in the USA, UK and Australia. Evident from the workshop and corresponding literature is that a multi-faceted approach to engaging communities is essential. This needs to be complemented by redesigning healthcare systems that improves access and raises awareness of the needs of these communities. At a more strategic level, institutions involved in funding research, commissioning and redesigning genetic health services also need to be adequately represented by underserved populations with intrinsic mechanisms to disseminate good practice and monitor participation. Further, as genomic medicine is mainstreamed, educational programmes developed for clinicians should incorporate approaches to alleviate disparities in accessing genetic services and improving study participation.

Citing Articles

"Equity" in genomic health policies: a review of policies in the international arena.

Basnayake Ralalage P, Mitchell T, Zammit C, Baynam G, Kowal E, Masey L Front Public Health. 2025; 12:1464701.

PMID: 39758206 PMC: 11695411. DOI: 10.3389/fpubh.2024.1464701.


Native Hawaiian and Pacific Islander populations in genomic research.

Ha E, Shriner D, Callier S, Riley L, Adeyemo A, Rotimi C NPJ Genom Med. 2024; 9(1):45.

PMID: 39349931 PMC: 11442686. DOI: 10.1038/s41525-024-00428-6.


Words matter: The language of difference in human genetics.

Cho M, Lasio M, Amarillo I, Mintz K, Bennett R, Brothers K Genet Med. 2022; 25(3):100343.

PMID: 36524987 PMC: 9991958. DOI: 10.1016/j.gim.2022.11.011.


Testing a deliberative democracy method with citizens of African ancestry to weigh pros and cons of targeted screening for hereditary breast and ovarian cancer risk.

Guan Y, Pathak S, Ballard D, Veluswamy J, McCullough L, McBride C Front Public Health. 2022; 10:984926.

PMID: 36424974 PMC: 9679525. DOI: 10.3389/fpubh.2022.984926.


Literacy-adapted, electronic family history assessment for genetics referral in primary care: patient user insights from qualitative interviews.

Mittendorf K, Lewis H, Duenas D, Eubanks D, Gilmore M, Goddard K Hered Cancer Clin Pract. 2022; 20(1):22.

PMID: 35689290 PMC: 9188215. DOI: 10.1186/s13053-022-00231-3.


References
1.
Fairchild A, Bayer R . Uses and abuses of Tuskegee. Science. 1999; 284(5416):919-21. DOI: 10.1126/science.284.5416.919. View

2.
Corbie-Smith G, Thomas S, Williams M . Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med. 1999; 14(9):537-46. PMC: 1496744. DOI: 10.1046/j.1525-1497.1999.07048.x. View

3.
Kaneko A, Lum J, Yaviong L, Takahashi N, Ishizaki T, Bertilsson L . High and variable frequencies of CYP2C19 mutations: medical consequences of poor drug metabolism in Vanuatu and other Pacific islands. Pharmacogenetics. 1999; 9(5):581-90. View

4.
Modell B, Harris R, Lane B, Khan M, Darlison M, Petrou M . Informed choice in genetic screening for thalassaemia during pregnancy: audit from a national confidential inquiry. BMJ. 2000; 320(7231):337-41. PMC: 27278. DOI: 10.1136/bmj.320.7231.337. View

5.
Laskey S, Williams J, Pierre-Louis J, ORiordan M, Matthews A, Robin N . Attitudes of African American premedical students toward genetic testing and screening. Genet Med. 2003; 5(1):49-54. DOI: 10.1097/00125817-200301000-00008. View